HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 81.84 -1.46 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $83.30 | 52 Week High | $18.39 | |||
| Open | $83.19 | 52 Week Low | $6.96 | |||
| Day High | $83.21 | P/E | N/A | |||
| Day Low | $81.50 | EPS | $-0.58 | |||
| Volume | 183,091 | |||||
